Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Rebetron now available in the U.S.

June 9, 1998

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

June 8, 1998

Zadaxin shows efficacy and safety in phase III trial for hepatitis B

June 8, 1998

Evaluation of rolipram in experimental animal models of colitis

June 5, 1998

FDA approves new combination therapy product for HCV

June 4, 1998

FDA advisory committee recommends approval of Avakine for Crohn's disease

May 29, 1998

Review study finds mesalamine most effective treatment for ulcerative colitis

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...